Stable solid dispersion of a derivative of vinca alkaloid and process for manufacturing it

Details for Australian Patent Application No. 2005321346 (hide)

Owner Pierre Fabre Medicament

Inventors Leverd, Elie; Ibarra, Marie-Dominique; Bougaret, Joel

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005321346

PCT Pub. Number WO2006/069938

Priority 11/025 348 30.12.04 US; 0414069 30.12.04 FR

Filing date 20 December 2005

Wipo publication date 6 July 2006

Acceptance publication date 23 June 2011

International Classifications

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 31/4375 (2006.01)

Event Publications

7 June 2007 PCT application entered the National Phase

  PCT publication WO2006/069938 Priority application(s): WO2006/069938

23 June 2011 Application Accepted

  Published as AU-B-2005321346

13 October 2011 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name Pierre Fabre Medicament, Application No. 2005321346, under INID (31), correct the priority number to 11/025,348

20 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005321406-Compounds that absorb ultraviolet light, methods of their preparation and optical lenses containing them

2005321344-Method for producing polyunsaturated long-chain fatty acids in transgenic organisms